128 related articles for article (PubMed ID: 36239100)
1. The combination of volumetric arc radiation therapy and boost high-dose rate interstitial brachytherapy for T3N2c tongue cancer: a technical report.
Murakami N; Sakuramachi M; Kashihara T; Chiba T; Nakamura S; Ono K; Ueno T; Yoshimoto S; Yoshida K; Masui K; Akiyama H; Igaki H
Jpn J Clin Oncol; 2023 Jan; 53(1):85-90. PubMed ID: 36239100
[TBL] [Abstract][Full Text] [Related]
2. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
4. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
5. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
[TBL] [Abstract][Full Text] [Related]
6. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
7. After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer.
Nakamura S; Murakami N; Inaba K; Wakita A; Kobayashi K; Takahashi K; Okamoto H; Umezawa R; Morota M; Sumi M; Igaki H; Ito Y; Itami J
BMC Cancer; 2016 May; 16():296. PubMed ID: 27142069
[TBL] [Abstract][Full Text] [Related]
8. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue.
Inoue T; Inoue T; Yoshioka Y; Yoshida K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170
[No Abstract] [Full Text] [Related]
9. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies.
Takácsi-Nagy Z; Martínez-Mongue R; Mazeron JJ; Anker CJ; Harrison LB
Brachytherapy; 2017; 16(1):44-58. PubMed ID: 27592129
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer.
Yoshida K; Takenaka T; Akiyama H; Yamazaki H; Yoshida M; Masui K; Kotsuma T; Baek S; Uesugi Y; Shimbo T; Yoshikawa N; Arika T; Koretsune Y; Yoshioka Y; Narumi Y; Tanaka E
J Radiat Res; 2014 Jan; 55(1):154-61. PubMed ID: 23732769
[TBL] [Abstract][Full Text] [Related]
11. High dose rate brachytherapy for early stage oral tongue cancer.
Leung TW; Wong VY; Kwan KH; Ng TY; Wong CM; Tung SY; Leung LC; O SK
Head Neck; 2002 Mar; 24(3):274-81. PubMed ID: 11891960
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Anticancer Res; 2006; 26(5B):3933-7. PubMed ID: 17094424
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer.
Inoue T; Inoue T; Teshima T; Murayama S; Shimizutani K; Fuchihata H; Furukawa S
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1201-4. PubMed ID: 8985043
[TBL] [Abstract][Full Text] [Related]
14. Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours.
Takácsi-Nagy Z; Ferenczi Ö; Major T; Akiyama H; Fröhlich G; Oberna F; Révész M; Poósz M; Polgár C
Strahlenther Onkol; 2022 Sep; 198(9):812-819. PubMed ID: 35157100
[TBL] [Abstract][Full Text] [Related]
15. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma.
Guinot JL; Santos M; Tortajada MI; Carrascosa M; Estellés E; Vendrell JB; Muelas R; Chust ML; Mengual JL; Arribas L
Brachytherapy; 2010; 9(3):227-34. PubMed ID: 20116340
[TBL] [Abstract][Full Text] [Related]
17. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers.
Sresty NV; Ramanjappa T; Raju AK; Muralidhar KR; Sudarshan G
Brachytherapy; 2010; 9(3):235-8. PubMed ID: 20116345
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
[TBL] [Abstract][Full Text] [Related]
20. High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer.
Inoue T; Inoue T; Teshima T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():287-90. PubMed ID: 10895168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
